Copertina

Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Manon Evain, Isaac Ruiz, Teresa Antonini, Guillaume Lassailly, Alessandra Mazzola, Pauline Houssel Debry, Laure Elkrief, Rodolphe Anty, Mylène Sebagh, Philippe Ichai, Daniel Cherqui, Didier Samuel, Ilias Kounis, Audrey Coilly
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study
di: Yi Xiang, et al.
Pubblicazione: (2025)

Letter: Unmasking the Risks—The Need for Robust Data on Baclofen in Cirrhotic Patients
di: Zainab Salman
Pubblicazione: (2026)

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression
di: Qun Zhang, et al.
Pubblicazione: (2025)

Letter: Methodological Caveats in Zhang et al.–Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension
di: Muhammad Talha Ghaffar
Pubblicazione: (2025)

Letter: Reinterpreting the Role of Microbiota‐Driven Nitric Oxide in Cirrhotic Portal Hypertension—A Maladaptive Compensatory Response?
di: Meiyu Yang, et al.
Pubblicazione: (2025)

Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non‐Cirrhotic Patients
di: Ming Liu, et al.
Pubblicazione: (2025)

Letter on ‘Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicentre Real‐World’
di: Silvia Nardelli, et al.
Pubblicazione: (2025)

Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective
di: Yassine Kilani, et al.
Pubblicazione: (2024)

Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study
di: Pinelopi Arvaniti, et al.
Pubblicazione: (2025)

Editorial: Understanding the Role of the Alpha‐1 Pi* MZ Genotype in the Development of Hepatocellular Carcinoma for Patients With ACLD
di: Kaitlyn Carlson, et al.
Pubblicazione: (2026)

Letter on ‘Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study’
di: Muhammad Ibrahim Khalil, et al.
Pubblicazione: (2025)

Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease
di: Moeko Komatsu, et al.
Pubblicazione: (2024)

Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )
di: Veeral Ajmera, et al.
Pubblicazione: (2026)

Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome
di: Lesley A. Houghton, et al.
Pubblicazione: (2025)

CD300A+CD8+ T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon‐Alpha Therapy
di: Peng Zhang, et al.
Pubblicazione: (2025)

Diagnostic Accuracy of an Add‐On, Blood‐Based Screening Test for Colorectal Cancer in Two Established Screening Programmes
di: Tim L. Kortlever, et al.
Pubblicazione: (2025)

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
di: Elsa L. S. A. van Liere, et al.
Pubblicazione: (2024)

No value of non‐selective beta‐blockers after TIPS‐insertion
di: Anja Tiede, et al.
Pubblicazione: (2024)

Editorial: The future of managing drug induced liver injury
di: Amanda Nicoll
Pubblicazione: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
di: Vibeke Strande, et al.
Pubblicazione: (2024)

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies
di: Jasmohan S. Bajaj, et al.
Pubblicazione: (2025)

Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study
di: Samantha Baillie, et al.
Pubblicazione: (2025)

Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021
di: Mehdi Osooli, et al.
Pubblicazione: (2025)

Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
di: Ting Wang, et al.
Pubblicazione: (2024)

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
di: Mathias Jachs, et al.
Pubblicazione: (2025)

Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers
di: Jun Tao, et al.
Pubblicazione: (2026)

Letter on ‘Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis’
di: Yi Pei, et al.
Pubblicazione: (2025)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
di: Liang Jiao, et al.
Pubblicazione: (2026)

Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study
di: Adam S. Faye, et al.
Pubblicazione: (2025)

Correction to ‘Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study’
Pubblicazione: (2024)

Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion
di: Cathy Lu, et al.
Pubblicazione: (2025)

Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis
di: Matthew K. W. Chu, et al.
Pubblicazione: (2025)

Letter: Interpreting Faecal SCFA Enrichment in IBS‐D—Metabolic Signal or Transit‐Related Marker?
di: Longying Zhang, et al.
Pubblicazione: (2026)

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
di: Jung Eun Park, et al.
Pubblicazione: (2024)

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
di: Yu‐Ping Chang, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Editorial: New Insights Into the Aetiopathogenesis of Post‐Infective Irritable Bowel Syndrome and Functional Dyspepsia: A Significant Step Forward but What Next? Authors' Reply
di: Mohamed H. Eldesouki, et al.
Pubblicazione: (2026)

Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
di: Jörn M. Schattenberg, et al.
Pubblicazione: (2026)

Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
di: Tyng‐Yuan Jang, et al.
Pubblicazione: (2025)

Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score‐Matched Study Using Linear Mixed‐Effects Models
di: Takashi Kumada, et al.
Pubblicazione: (2026)